Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Budesonide and Rectal Hydrocortisone in Extensive Ulcerative Colitis
NCT00805285Phase 2Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- Oct 2008
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of EPI-EE in ulcerative colitis (UC), sponsored by University of Maryland, Baltimore. Started Oct 2008; status: terminated.
02
Drugs
EPI-EE
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00805285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00805285.